Luan Chengxin, Chen Runzhe, Chen Baoan, Ding Jiahua, Ni Ming
Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.
Patient Prefer Adherence. 2015 Jun 11;9:759-65. doi: 10.2147/PPA.S81509. eCollection 2015.
Delayed hematopoietic recovery and increased rate of engraftment failure limit the use of umbilical cord blood transplantation (UCBT). We describe a case of severe aplastic anemia treated by UCBT combined with mesenchymal stem cells. Our case reveals that infusing mesenchymal stem cells early (about 40 days) after UCBT may promote hematopoietic recovery. This experience will guide clinical scientists, especially hematologists, to deal with similar situations and encourage them to widen this strategy.
延迟的造血恢复和移植失败率增加限制了脐带血移植(UCBT)的应用。我们描述了一例采用UCBT联合间充质干细胞治疗的重型再生障碍性贫血病例。我们的病例显示,在UCBT后早期(约40天)输注间充质干细胞可能促进造血恢复。这一经验将指导临床科学家,尤其是血液学家,处理类似情况,并鼓励他们推广这一策略。